Are you a Medical Practitioner wanting to order BREASTEST plus™ - Click here to find out more

Investors

Advancing Breast Cancer Screening With A Non-invasive Blood Test

ASX:BDX → $0.055

About BCAL Diagnostics

BCAL Diagnostics Limited (ASX: BDX, BCAL) is an Australian biotechnology company dedicated to advancing early and accurate breast cancer diagnosis.

BCAL is an R&D company with a revenue-generating diagnostic service business, with commercial operations underway through its NATA-accredited laboratory in Sydney. The company is now focused on scaling delivery of BREASTEST plus ™ and building market adoption while continuing to invest in R&D to expand its product pipeline, drive innovation, and unlock long-term growth opportunities.

Our innovative, non-invasive blood test, BREASTEST plus™ is designed to complement existing breast screening. Developed in partnership with doctors, BREASTEST plus™ provides additional diagnostic information – particularly for women with dense breast tissue – to support greater confidence in clinical decision-making and breast health management.

Close-up view of a collection of colorful laboratory test tubes arranged in a rack, showcasing various cap colors used for different blood sample types in medical testing.
Female doctor assisting female patientFemale doctor operating laptop

ASX Announcements

Financial Reports

Latest Presentations

Corporate Governance

The Board of BCAL Diagnostics is committed to transparency, integrity, and accountability, ensuring our governance framework supports long-term growth and sustainability.

A strong, values-based governance structure is fundamental to our company, guiding ethical decision-making and responsible business practices. We align with best practice principles and the ASX Corporate Governance Council’s recommendations to uphold these standards.

For more details, download our key policies below.

Join Our Team in Transforming Breast Cancer Diagnostics

We invite you to take the next step:

  • Support our mission by exploring investment opportunities with BCAL Diagnostics (ASX: BDX).

Contact our Investors Relations Team today.

Contact Us